Cholestane-3beta, 5alpha, 6beta-triol promotes vascular smooth muscle cells calcification.
Oxysterols found in atherosclerotic plaque may be associated with vascular calcification. We investigated the effect of oxysterol cholestane-3beta, 5alpha, 6beta-triol (Triol) on in vitro calcification of rat vascular smooth muscle cells (VSMCs). In vitro calcification was induced by incubation of VSMCs with beta-glycerophosphate. Calcifying nodule formation, calcium deposition in extracellular matrix, and alkaline phosphatase (ALP) activity were measured as indices of calcification. Because apoptotic bodies can serve as nucleation sites for calcification, apoptosis of calcifying VSMCs was determined by Hoechst 33258 staining, TUNEL, and FITC-labeled annexin V/PI double staining. The calcium deposition and ALP activity in calcifying VSMCs were much higher than those in non-calcifying VSMCs. Triol increased calcifying nodule formation, calcium deposition, ALP activity, and apoptosis of nodular cells in calcifying VSMCs. As determined by 2,7-dichlorofluorescein fluorescence, Triol induced the generation of reactive oxygen species (ROS) in calcifying VSMCs dose- and time-dependently. Triol-induced increases in calcium deposition, ALP activity, apoptosis, and ROS generation were all attenuated by antioxidant vitamin C plus vitamin E (VC + VE). The results demonstrated that Triol promoted VSMCs calcification through direct increase of ALP activity and apoptosis, probably by ROS-related mechanism.
Liu
Hongmei
H
Department of Chemical Biology, Peking University School of Pharmaceutical Sciences, 38 Xueyuan Road, Beijing 100083, PR China.
Yuan
Lan
L
Xu
Shanjin
S
Zhang
Tianlan
T
Wang
Kui
K
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002114:Calcinosis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D002777:Cholestanols / Q000494:pharmacology*; D005109:Extracellular Matrix / Q000378:metabolism; D005994:Glycerophosphates / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D014652:Vascular Diseases / Q000209:etiology* / Q000378:metabolism / Q000473:pathology
D002777:Cholestanols; D005994:Glycerophosphates; D017382:Reactive Oxygen Species; C000474:cholestane-3,5,6-triol; D000469:Alkaline Phosphatase; D002118:Calcium